Neurodevelopmental Outcome in Infants of Gestational Diabetic Mother in a Tertiary Care Hospital, Dhaka, Bangladesh
Journal Title: Journal of Clinical Medical Research - Year 2024, Vol 5, Issue 3
Abstract
Background: Diabetes Mellitus (DM) is one of the most common metabolic complications of pregnancy, with negative influences on maternal and fetal health. Infants of Diabetic Mothers (IDMs) are prone to develop both early and late complications. Evidences shows that diabetes in pregnancy have strong association with long-term adverse effects on brain development in babies born to mothers with gestational diabetes mellitus. Very few studies were done in this subcontinent regarding association of gestational diabetes mellitus and infant’s neurodevelopmental outcome. This study will help to find out this associations and thus to reduce poor neurodevelopmental outcome in infants of diabetic mothers by early detection and providing proper early childhood stimulation. Objective: To assess the neurodevelopmental outcome of infants born to mother with gestational diabetes mellitus. Methodology: This prospective observational study was conducted in the department of Neonatology and Institute of Pediatric Neurodisorder and Autism (IPNA), BSMMU, from March 2022 to September 2023. Neonates (N= 52) born at or after 34 weeks of gestation and born to gestational diabetic mother were enrolled in this study. Consent was taken from guardians. The newborns fulfilling the inclusion criteria were followed up for neurodevelopmental assessment at their 9 months of age by clinical psychologists assigned from Institute of Pediatric Neurodisorder and Autism (IPNA), BSMMU, who were blinded about infant’s diagnosis. Bayley scales of infant and toddler development (BSID III) was used for developmental assessment. In the Bayley III, cognitive development, expressive and receptive language and fine and gross motor development all were evaluated at 9 months of age. All data were recorded in a preformed questionnaire and analyzed by Statistical Package for Social Sciences (SPSS), version 25. Results: According to inclusion and exclusion criteria 58 newborn were enrolled and their blood samples were sent at 24 to 48 hours of age to see the laboratory parameters of metabolic and hematological profile. Among them 6 patients lost to follow up, so 52 infants were followed up for neurodevelopmental outcome at 9 months of age. Among the baseline characteristics of mother and neonate 48% mother needed drugs for glycemic control, while others were on dietary modification and 75% of the mothers had good glycemic control. Most of the neonate were born at term and were age appropriate, 18 patients needed NICU admission. Among the neonatal laboratory parameters hyperbilirubinemia was most common (30.8%) and hypoglycemia was second most common found in 15.4% of newborns. The most common morbidity was sepsis (17.3%). Overall adverse neurodevelopmental outcome was found among 14 (26.9%) neonate and 38 (73.1%) neonates had favorable outcome. Use of drugs and poor maternal glycemic control were found statistically significant in between adverse and favorable groups. (p-value- 0.041 and 0.000). Among the neonatal clinical parameters only hypoglycemia was found statistically significant in between these two groups. (p-value- 0.014) Multivariate logistic regression among these predictive factors showed only maternal poor glycemic control was significantly associated with adverse neurodevelopmental outcome (p-value=0.001). Conclusion: Maternal gestational diabetes can adversely affect on their infants neurodevelopment. Among the adverse outcome of three domains language delay was most common. Neonatal hypoglycemia, maternal poor glycemic control and use of drugs for GDM are significant predictors of adverse neurodevelopmental outcome in infants of gestational diabetic mother. Among them maternal poor glycemic control was significantly associated with adverse neurodevelopmental outcome.
Authors and Affiliations
Maria Mahabub1, Rumpa Mani Chowdhury2, Mohammad Kamrul Hassan Shabuj3, Sadeka Choudhury Moni4, Ismat Jahan5, M A Mannan6*, Sanjoy Kumer Dey7, M Shahidullah8
Keywords
Related Articles
- EP ID EP750275
- DOI https://doi.org/10.46889/JCMR.2024.5308
- Views 36
- Downloads 0
ChatGPT/AI in Healthcare Management
ChatGPT is forging a revolution in the realm of human-computer interaction, establishing new paradigms for what artificial intelligence can achieve. Also known as the Generative Pretrained Transformer (GPT), ChatGPT repr...
Molecular Diagnosis of Resistant Tuberculosis Against Rifampicin to the Patients of the Centre Hospitalier Universitaire de Référence Nationale (CHU-RN): Preliminary Study During the COVID-19 Pandemic Period in N’Djamena, Chad
Background: The fight against Tuberculosis (TB) remains a challenging public health problem worldwide. Nowadays, resistance forms increase sharply in developed countries. With a rifampicin resistance rate of 7.2% higher...
Cut-down Access to Avoid Vascular Complications During Transcatheter Aortic Valve Implantation
Objective: Vascular Complications (VCs) are independent predictors of mortality after Transcatheter Aortic Valve Implantation with Transfemoral Access (TF-TAVI) and remain an unsolved problem regardless of the Percutaneo...
Precision Drugs
The mantra of precision medicine is to prevent and treat diseases by considering individual variability in genes, environment and lifestyle for each person. However, precision drugs to enable precision medicine are not y...
Correlation of Chest Radiological Findings with Biochemical Markers on Oxygen Requirement in COVID-19 Patients: A Retrospective Analysis
Background: The study is to correlate Chest X-ray scoring with the laboratory markers and to determine the oxygen requirement in COVID-19 patients. Methodology: We conducted a retrospective study in COVID confirmed pa...